Screener
Ginkgo Bioworks DNA EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Ginkgo Bioworks’s reported figures.
Plus components not separately reported this period.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
FAQ
- What is Ginkgo Bioworks's EBIT?
- Ginkgo Bioworks (DNA) reported EBIT of -$58.55M in Q2 2026.
- How has Ginkgo Bioworks's EBIT changed year-over-year?
- Ginkgo Bioworks's EBIT decreased by 0.7% year-over-year, from -$58.16M to -$58.55M.
- What is the long-term trend for Ginkgo Bioworks's EBIT?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's EBIT has grown at a -36.4% compound annual growth rate (CAGR), from -$1.83B to -$299.9M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Ginkgo Bioworks's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude